瓦氏视网膜病变:临床特征与治疗结局
该回顾性病例系列纳入2010年6月1日至2020年5月31日诊断的瓦氏视网膜病变58眼(58例),最常见病因为举重物(34.4%)、呕吐(20.6%)、用力(20.6%)和咳嗽(17.2%)。诊断时平均最佳矫正视力为20/163,1年时恢复至20/22;观察组出血临床消退平均时间为99.0±18.7天,玻璃体切割术后为4.5±3.5天。结论认为该病总体视力预后良好,多数眼观察即可,需快速清除出血者可考虑玻璃体切割术。
要点
- 最常见病因为举重物(34.4%),其次为呕吐和用力(各20.6%)、咳嗽(17.2%)。
- 出血最常累及玻璃体下间隙(42.3%),其次为视网膜内(32.7%)、玻璃体内(23.1%)、视网膜下(13.4%)。
- 观察组出血消退平均99.0±18.7天,玻璃体切割术后平均4.5±3.5天。
核心结论
- 瓦氏视网膜病变通常与良好的视力预后相关,多数眼观察即可获得良好结局,需快速清除出血者可考虑玻璃体切割术。
研究设计与样本
- 回顾性病例系列,纳入2010年6月1日至2020年5月31日诊断为瓦氏视网膜病变的患者,共58眼(58例),复习临床记录、手术报告、眼底照相和光学相干断层扫描图像。
主要发现
- 最常见病因为举重物(34.4%)、呕吐(20.6%)、用力(20.6%)和咳嗽(17.2%)。
- 诊断时平均最佳矫正视力为20/163;全部患者平均最佳矫正视力3个月时为20/59,6个月时为20/48,1年时为20/22。
- 最常累及的玻璃体视网膜间隙为玻璃体下间隙(42.3%),其次为视网膜内(32.7%)、玻璃体内(23.1%)和视网膜下(13.4%)。
- 观察组出血临床检查消退平均时间为99.0±18.7天,接受玻璃体切割术者术后平均为4.5±3.5天。
临床怎么用
- 原文结论认为多数眼观察即可获得良好视力预后,需快速清除出血者可考虑玻璃体切割术。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To report the clinical presentation and outcomes in patients with Valsalva retinopathy. METHODS: This was a retrospective case series of patients diagnosed with Valsalva retinopathy between June 1, 2010, and May 31, 2020. Clinical notes, operative reports, fundus photography, and optical coherence tomography images were reviewed. RESULTS: This study comprised 58 eyes of 58 patients. The most common causes were lifting (34.4%), vomiting (20.6%), straining (20.6%), and coughing (17.2%). Mean best-corrected visual acuity at diagnosis was 20/163. The most frequently involved vitreoretinal compartment was the subhyaloid space (42.3%) followed by the intraretinal (32.7%), intravitreal (23.1%), and subretinal (13.4%) spaces. Mean best-corrected visual acuity of all patients was 20/59 at 3 months, 20/48 at 6 months, and 20/22 at 1 year. Mean time to clearance of hemorrhage on clinical examination was 99.0 ± 18.7 days in patients who underwent observation and 4.5 ± 3.5 days after surgery in patients who received pars plana vitrectomy. CONCLUSION: Valsalva retinopathy is generally associated with a favorable visual prognosis. Most eyes perform well with observation although pars plana vitrectomy may be indicated in patients requiring rapid resolution of hemorrhage.
引用
- Rohowetz LJ, Patel V, Sridhar J, et al. VALSALVA RETINOPATHY: Clinical Features and Treatment Outcomes. Retina. 2023. PMID: 36893442. doi:10.1097/IAE.0000000000003772
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。